Skip to main content
  • Stories
  • Partner with us
  • Careers
Immedica Pharma
  • About us
  • Therapeutic areas
  • Products
  • Sustainability
  • Media
  • Contact

Press releases

Stay up to date by subscribing to our latest press releases.

Sign up
  1. Home
  2. Media
  3. Press releases
2018-12-21 12:00
We, Medical Need and Immedica Group, are moving!
2018-12-18 10:00
Immedica gains the right to anti-tumor agent Yondelis[®]in the United Kingdom
2018-11-12 10:45
Immedica expands its management team - Nina Fleck and Håkan Garpenstrand joins Immedica
2018-08-13 14:00
Immedica - a platform for pan-European niche specialty pharma launch, commercialization and distribution services

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11

Immedica Pharma AB

  • Partner with us
  • ESG
  • Products
  • Contact

Immedica Pharma AB
Solnavägen 3H
113 63 Stockholm
Sweden

  • LinkedIn

Code of Conduct | GDPR | Terms of use | Reporting of misconducts | Cookie Notice | Cookie settings
© 2023 All rights reserved | Delivered by Investis Digital [iDX]

  • About us
    • Rare diseases
    • Strategy and business model
    • Organization
    • Our vision & mission
    • Board of Directors
    • Management team
    • CEO statement
  • Therapeutic areas
    • Genetic & Metabolic diseases
    • Hematology & Oncology
    • Specialty Care
  • Products
  • Sustainability
    • Commitment to make a difference to patients’ lives
    • Sustainable organization and operations
    • Sustainability report
    • Transparency
    • Sustainability Report Archive
    • Reporting of misconducts
  • Media
    • Press releases
    • Multi-language press releases
    • Calendar
    • Image bank
    • Subscribe
    • Annual Report Archive
  • Contact
    • Headquarter
    • Local contacts
    • Medical information contacts
    • Ordering
    • Safety and product complaints
  • Stories
  • Partner with us
  • Careers
Young Woman
Our vision & values

We believe we have an important role to fill in society – bringing new, innovative treatments to patients with rare diseases.

About us
Rare diseases
Strategy and business model
Organization
Our vision & mission
Board of Directors
Management team
CEO statement
Mom & Daughter
Our focus areas

Focus areas are within genetic & metabolic diseases, hematology & oncology and specialty care.

Therapeutic areas
Genetic & Metabolic diseases
Hematology & Oncology
Specialty Care
Newborn feet
Our products

We operate products from phase 2 and all the way to mature products.

Products
Woman
Sustainability report 2023

ESG is an integrated part of our business model.

Sustainability
Commitment to make a difference to patients’ lives
Sustainable organization and operations
Sustainability report
Transparency
Sustainability Report Archive
Reporting of misconducts
Coworkers
Subscription service

Stay up to date with our latest news.

Media
Press releases
Multi-language press releases
Calendar
Image bank
Subscribe
Annual Report Archive
HQ
Contact us

Telephone: +46 (0) 8 533 39 500
E-mail: [email protected]

Contact
Headquarter
Local contacts
Medical information contacts
Ordering
Safety and product complaints